J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 Jan 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of late April 2026. While the stock price has shown resilience with a 0.95% gain on the day, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and Bollinger Bands reveals a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

J B Chemicals & Pharmaceuticals Ltd has experienced a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend. Despite mixed signals from key indicators such as MACD and RSI, the stock’s recent performance and moving averages suggest growing investor confidence in this pharmaceuticals & biotechnology small-cap.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

J B Chemicals & Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. While monthly indicators maintain a positive outlook, weekly signals suggest caution, highlighting a complex landscape for investors navigating this small-cap pharmaceutical stock.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook.

J B Chemicals & Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is supported by a confluence of technical indicators including MACD, moving averages, and Bollinger Bands, signalling potential upside for investors amid a mixed broader market environment.

J B Chemicals & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early April 2026. Despite a recent day decline of 2.46%, the stock’s technical indicators present a complex picture, with some signals suggesting sustained strength while others hint at caution for investors navigating the Pharmaceuticals & Biotechnology sector.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 March 2026, providing investors with the latest insights into its performance and outlook.

Surging past its previous peak, J B Chemicals & Pharmaceuticals Ltd touched a fresh 52-week high of Rs 2195 on 20 Mar 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and outperformance relative to its sector and the broader market.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2171.4 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2140.25 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2129.9 today, marking a notable achievement in its stock performance amid a challenging broader market environment.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs. 2119.85 on 10 Mar 2026, marking a notable surge in its stock price amid a mixed market environment.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 March 2026, providing investors with the latest insights into its performance and outlook.

J B Chemicals & Pharmaceuticals Ltd has reached a significant milestone by hitting a new 52-week high of Rs.2112.55 today, marking a continuation of its strong upward momentum in the Pharmaceuticals & Biotechnology sector.

J B Chemicals & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.